David Dewhurst can kiss my big blue butt.  On Sunday.  In the park.  And I’ll even spot him 15 minutes to draw a crowd.

David Dewhurst: so slick that he can't keep his socks up.

Dewhurst put a venture capitalist on the state cancer research board, where he will vote on over $3 billion in state funds for cancer research, where he just happens to have a little interest.

And what did this prime appointment cost Charles Tate?  $465,000 to Dewhurst’s political funds for his statewide races.  Hey, half a million for 3 billion?  Nice return on his investment, no?

Over the past six weeks, the state cancer institute has been generating headlines, after The Dallas Morning News reported that chief scientific reviewer Alfred Gilman quit in protest of geographic-quota politics and a short-circuiting of grant reviews by panels of out-of-state scientists. Among other things, Gilman criticized the institute’s hasty award in March of $20 million to a business incubator partnership between Rice University and M.D. Anderson. Over the weekend, the Houston Chronicle reported emails suggest Tate was instrumental in shepherding the incubator grant, which will help fund cancer researcher Lynda Chin, wife of M.D. Anderson president Ronald DePinho, through the institute’s approval process.

Maybe if Dewhurst gets elected to the senate, he can sell squeaky wheelchair rights for little crippled children or think of the money there has to be in prosthetic devices that don’t even have to work properly!  That’s a whole new frontier for Dewhurst:  sick people to exploit all over the country!

Republicans:  they are selling your cancer drugs to the highest venture capitalist  bidder.  That’s just gotta make you proud.

Seriously, selling state cancer research funds has to earn you a real special place in hell.

Thanks to David for the heads-up.